Presented by: 
Joshua Ross (Adelaide)
Mon 16 Jul, 2:00 pm - 3:00 pm
442 Priestley (67)

Antiviral treatment offers a fast acting alternative to vaccination. It is viewed as a first line of defence against pandemic influenza, protecting families and household members once infection has been detected. In clinical trials antiviral treatment has been shown to be efficacious in preventing infection, limiting disease and reducing transmission, yet their impact at containing the 2009 influenza A(H1N1)pdm pandemic was limited. I will describe some of our work, which attempts to understand this seeming discrepancy, through the development of a general model and computationally efficient methodology for studying household-based interventions.

This is joint work with Dr Andrew Black (Adelaide), and Prof. Matt Keeling and Dr Thomas House (Warwick, U.K.).